Tirzepatide (Zepbound, FDA-approved for weight management) functions as both a GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
Side Effects of Retatrutide: What the Trial Data Shows Retatrutides side effect profile is broadly consistent with other GLP-1 medications, with additional considerations at higher doses
At this time, it is uncertain how participating beneficiaries will be able to maintain Medicare coverage of their GLP-1 medication for obesity after the Medicare GLP-1 Bridge ends at the end of 2027, pending further action from CMS to implement the BALANCE Model in Medicare Part D in 2028, as described below
You can induce natural NAD+ production by increasing exercise and keeping a lean body weight
It may help people who need better blood sugar control
Always check with your healthcare practitioner first, as everyone has different health needs, and some supplements may interact with medications